pAb/mAb to Human Neurological Disorders
Product Specificity |
Catalogue # |
Application |
Size |
Price (USD) |
Details |
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12 |
MO-M40100D |
EIA |
0.1 mg |
|
Details |
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1 |
MO-M40100C |
EIA |
0.1 mg |
|
Details |
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1 |
MO-M40100E |
EIA |
0.1 mg |
|
Details |
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11 |
MO-M40100F |
EIA |
0.1 mg |
|
Details |
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11 |
MO-M40100G |
EIA |
0.1 mg |
|
Details |
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1 |
MO-M40100A |
EIA |
0.1 mg |
|
Details |
mAb anti-Human α-Synuclein, 4B4 |
MO-M40097C |
EIA, WB |
0.1 mg |
|
Details |
mAb anti-Human α-Synuclein, 4C1 |
MO-M40097B |
EIA, WB |
0.1 mg |
|
Details |
mAb anti-Human α-Synuclein, 4H11 |
MO-M40097A |
EIA, WB |
0.1 mg |
|
Details |
mAb anti-Human α-Synuclein, 8F12 |
MO-M40097D |
EIA, WB |
0.1 mg |
|
Details |